Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used? - The Sick Times

Recent studies add evidence to a prior phase 3 clinical trial, suggesting that taking the diabetes drug during acute COVID-19 reduces the risk of long-term symptoms.

The Sick Times - Chronicling the Long Covid crisis